Yellow fever vaccine-associated viscerotropic disease is a rare sequela of live-attenuated virus vaccine. Elderly persons and persons who have had thymectomies have increased susceptibility. A review of published and other data suggested a higher than expected number of deaths from yellow fever vaccine-associated viscerotropic disease among women 19-34 years of age without known immunodeficiency.
No takes yet. Share an insight, caveat, or question.
Stephen Seligman (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: